Luke Rothermel, MD, MPH
- Assistant Professor, CWRU School of Medicine
- Specialty: Surgical Oncology, General Surgery
-
Location:UH Cleveland Medical Center Bolwell
11100 Euclid Ave
Cleveland, OH 44106
- Call: 216-844-7874
Biography: Luke Rothermel, MD, MPH
Expertise
Certifications & Memberships
- Complex General Surgical Oncology - American Board of Surgery
- Surgery - American Board of Surgery
Education
Fellowship | Surgical Oncology
Surgical Oncology - H Lee Moffitt Cancer Center And Research Institute (2017 - 2019)
Research Fellowship | Surgical Oncology
Surgical Oncology - National Cancer Institute (NCI) (2012 - 2014)
Residency | General Surgery
General Surgery - UH Cleveland Medical Center (2010 - 2017)
Other Education
Wright State University (2010)
Medical Education
Wright State University Boonshoft School Of Medicine (2010)
Undergraduate
Capital University (2005)
About
Luke Rothermel, MD, MPH, is a surgical oncologist and Chief – Section of Soft Tissue and GI Surgery, Division of Surgical Oncology at University Hospitals Seidman Cancer Center. He is also an Assistant Professor at Case Western Reserve University. Dr. Rothermel’s main areas of clinical interest are melanoma, sarcoma and peritoneal surface cancers. In 2019, UH Seidman Cancer Center recruited Dr. Rothermel to help lead its melanoma and sarcoma disease teams.
Dr. Rothermel earned his Bachelor of Arts in Biology at Capital University (Columbus, Ohio) in 2005. He then attended Wright State University (Dayton, Ohio), where he earned both his Master of Public Health and medical degree (Wright State University Boonshoft School of Medicine) in 2010. Dr. Rothermel’s post-graduate medical training included a clinical research fellow completed in 2014 at National Cancer Institute (Bethesda, Maryland), a general surgery residency completed in 2017 at University Hospitals Cleveland Medical Center (Cleveland, Ohio), and a complex general surgical oncology fellow completed in 2019 at Moffitt Cancer Center (Tampa, Florida).
As a researcher, Dr. Rothermel pursues research aimed at identifying new metabolic strategies for managing advanced melanomas, including efforts to prevent or overcome resistance to standard melanoma therapies. Dr. Rothermel also collaborates with scientists and staff at the Case Comprehensive Cancer Center to improve the assessment and navigation of cancer patients who encounter barriers to achieving the best treatment outcomes.
Dr. Rothermel has contributed original articles to various peer-reviewed journals, among them Cancer Research, Clinical Cancer Research, Journal of Experimental and Clinical Cancer Research, and Annals of Surgical Oncology. In addition, he has served as a reviewer for the Journal of the American Medical Association Dermatology, Annals of Surgical Oncology, Journal of Surgical Oncology, and Journal of the National Comprehensive Cancer Network, among others.
As an educator, Dr. Rothermel has presented, lectured or performed grand rounds at conferences and symposiums hosted by University Hospitals, the American Society of Dermatologic Surgery, Dignity Health – Cancer Institute at St. Joseph’s Hospital and Medical Center, Riverside/Ohio Health Medical Association, and other organizations. Among other topics, Dr. Rothermel has lectured on the management of melanomas, retroperitoneal sarcomas, extremity sarcomas and liposarcomas. He has submitted abstracts and/or presented at meetings of the Society of Surgical Oncology, Academic Surgical Congress, Central Surgical Association, American College of Surgeons, The Americas Hepato-Pancreato-Biliary Association, and American Psychosocial Oncology Society, among other medical associations.
Professional societies in which Dr. Rothermel is a member include the American College of Surgeons, Society of Surgical Oncology, Association of Academic Surgeons, American Society of Clinical Oncology, Cleveland Surgical Society, Ohio American College of Surgeons, and the National Comprehensive Cancer Network (NCCN).
Featured Videos
Watch to find out more about this University Hospitals provider.
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Luke Rothermel did not disclose any Outside Relationships with Industry.